|
|
Second Annual Award Recipient
Olufunmilayo Falusi Olopade, MD, FACP
Walter L. Palmer Distinguished Service Professor
of Medicine and Human Genetics
Associate Dean for Global Health
University of Chicago Medical Center
Chicago, IL
|
Dr. Olufunmilayo Falusi Olopade will deliver her award lecture entitled Closing the Knowledge Disparity Gap: From Molecular Mechanisms to Interventions and Back during the Fourth Annual AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, Washington, DC. The award presentation and lecture will be held on Sunday, September 18, 2011, during the Opening Plenary Session.
- Learn more about the 2011 Award Recipient
- Read more about the AACR Conference on the Science of Cancer Health Disparities.
The Award and Lecture
The AACR Distinguished Lecture on the Science of Cancer Health Disparities, funded by Susan G. Komen for the Cure®, recognizes an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or prevention of cancer health disparities.
The recipient of the award will receive a $5,000 honorarium and present a 45-minute lecture at the Fourth Annual AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. The conference will be held September 18-21, 2011, in Washington, DC.
Eligibility
- All cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry or government.
- The award will be presented to an individual investigator.
- Institutions or organizations are not eligible for the award.
Nomination Process
Nominations are closed.
Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves.
The following materials must be submitted:
Nomination Letter, which must:
- be addressed to the Selection Committee, be written in English, and not exceed 1,000 words;
- specify the AACR lectureship for which the candidate is being nominated;
- describe the candidate whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or prevention of cancer health disparities. The publications supporting the work should be directly referenced within the letter.
Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.
Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.
Preferred file format is a .doc. The candidate's CV may be submitted as a PDF file. The nomination is not considered fully submitted until the nominator receives a confirmation e-mail from the AACR; confirmations will be sent within two business days.
Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.
There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators who may write nomination letters or who may sign a single nomination letter on behalf of a candidate.
Selection Process
Candidates will be considered by a Committee. After careful deliberation by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the award recipient will be made on the basis of the candidate's scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. For more than 25 years, Komen for the Cure has played a critical role in every major advance in the fight against breast cancer - transforming how the world talks about and treats this disease and helping to turn millions of breast cancer patients into breast cancer survivors.
Questions?
Linda Brooks-Stokes, Program Associate
awards@aacr.org
American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
(267) 646-0578
SPOTLIGHT
|
|
Second Annual Award Recipient
Olufunmilayo Falusi Olopade, MD, FACP
Walter L. Palmer Distinguished Service Professor
of Medicine and Human Genetics
Associate Dean for Global Health
University of Chicago Medical Center
|
Dr. Olufunmilayo Falusi Olopade is honored for her leading work in the study of breast cancer genetics in women.
Dr. Olopade is Walter L. Palmer distinguished service professor of medicine and associate dean for global health at The University of Chicago Medical Center.
Dr. Olopade graduated with distinction from the University of Ibadan College of Medicine in Nigeria and completed her residency training in internal medicine at Cook County Hospital where she also served as chief resident. Trained broadly in clinical hematology/oncology and cancer genetics at The University of Chicago, Dr. Olopade’s research has focused on understanding familial forms of cancer. Her seminal observations on the genetic basis of breast cancer in young women of African ancestry in the U.S. and West Africa has broadened our understanding of the complex interactions of genes, lifestyle and the environment in breast cancer causation.
As a physician and scientist, Dr. Olopade works tirelessly to translate scientific discoveries at the individual and population level into optimal interventions for women at risk of breast cancer. Dr. Olopade effectively disseminates the benefits of her work, inspires students and colleagues, and is a role model for women scientists worldwide.
A global leader in academic medicine, Dr. Olopade has received numerous honors and awards, including the ASCO Young Investigator Award, the James S. McDonnell Foundation Scholar Award, the Doris Duke Distinguished Clinical Scientist Award and the MacArthur Foundation Genius Award.
Dr. Olopade is a member of the Institute of Medicine of the National Academies, the National Cancer Advisory Board, the American Philosophical Society and a fellow of the American Academy of Arts and Sciences. Dr. Olopade is a member of the National Cancer Advisory Panel.